Preparation and preliminary biodistribution of "no carrier added" fluorine1-8 fluoroethanol.
T J Tewson, M J Welch
Index: J. Nucl. Med. 21(6) , 559-64, (1980)
Full Text: HTML
Abstract
No-carrier-added [18F] fluoroethanol has been prepared by two routes. The first involves fluoride-ion displacement on alpha-p-toluene sulfonyl ethyl glycolate followed by reduction of the alpha-fluoroethyl acetate. The second involves a ring-opening reaction on glycol sulfite to give an alpha-fluorosulfinic acid derivative that is hydrolyzed to fluoroethanol. The specific activity was measured as 10(5) Ci/millimole, and the stable fluorine-19 was traced to the cesium hydroxide used to trap the H18F. Following intracarotid injection, the labeled fluoroethanol was not trapped in the brain, and thus is not a microsphere analog as has been suggested. Tomographic images of the myocardium were obtained using the fluoroethanol as a tracer.
Related Compounds
Related Articles:
2014-09-01
[J. Pharm. Biomed. Anal. 98 , 446-62, (2014)]
2015-01-12
[ChemPhysChem 16(1) , 160-8, (2015)]
1980-05-15
[Experientia 36(5) , 537-9, (1980)]
1982-01-01
[Fukushima J. Med. Sci. 28(3-4) , 83-92, (1982)]
2003-02-01
[Acta Crystallogr. D Biol. Crystallogr. 59(Pt 2) , 274-89, (2003)]